Skip to Content

BioInfra Life Science Inc 266470 Stock Quote

| Rating as of

Morningstar‘s Stock Analysis 266470

Currency in KRW
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics 266470

Company Profile 266470

Business Description

BioInfra Life Science Inc is a bio-technology company engaged in developing cancer gene treatments and technologies that systematically monitor the possibility of metastasis and recurrence in blood for cancer patients.

Daehak-ro 49, 7th Floor, Jongno-gu
Seoul, 03127, Korea, Republic of
Industry Biotechnology
Most Recent Earnings Mar 31, 2020
Fiscal Year End Dec 31, 2020
Employees 29